SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/C27DC0435E858CDAFF79B664F63954B10F3560436CBC69D4FF3DDDBDE19E5706FB2B6D70E7505090CFC42F35F8405794>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/C27DC0435E858CDAFF79B664F63954B10F3560436CBC69D4FF3DDDBDE19E5706FB2B6D70E7505090CFC42F35F8405794
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/C27DC0435E858CDAFF79B664F63954B10F3560436CBC69D4FF3DDDBDE19E5706FB2B6D70E7505090CFC42F35F8405794
http://www.w3.org/2000/01/rdf-schema#comment
"VKORC1-CYP2C9 interaction can affect warfarin stable dosage."
xsd:string
http://purl.uniprot.org/uniprot/#_C2DAB21206388BBE1AF095EC82E9B034E7744F2FC3EFFB7ADB6F71E73EB1BB674BB5751DE1442059D5DB72724151DEC1
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/C27DC0435E858CDAFF79B664F63954B10F3560436CBC69D4FF3DDDBDE19E5706FB2B6D70E7505090CFC42F35F8405794
http://purl.uniprot.org/uniprot/Q9BQB6
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/C27DC0435E858CDAFF79B664F63954B10F3560436CBC69D4FF3DDDBDE19E5706FB2B6D70E7505090CFC42F35F8405794
http://purl.uniprot.org/uniprot/#_Q9BQB6-mappedCitation-25187307
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/C27DC0435E858CDAFF79B664F63954B10F3560436CBC69D4FF3DDDBDE19E5706FB2B6D70E7505090CFC42F35F8405794